Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 19,866 | 22,578 | 19,342 | 10,701 | 12,251 |
| Cost of Goods | 4,687 | 5,581 | 3,279 | 4,400 | 2,715 |
| Gross Profit | 15,179 | 16,997 | 16,063 | 6,301 | 9,536 |
| Operating Expenses | 45,144 | 52,185 | 41,316 | 51,739 | 61,173 |
| Operating Income | -29,278 | -34,607 | -24,974 | -45,038 | -50,922 |
| Interest Expense | 10,227 | 7,612 | 7,680 | 7,027 | 6,262 |
| Other Income | 122 | 132 | 42 | 89 | 335 |
| Pre-tax Income | -39,383 | -42,087 | -32,612 | -51,976 | -56,849 |
| Net Income Continuous | -39,383 | -42,087 | -32,612 | -51,976 | -56,849 |
| Net Income | $-39,383 | $-42,087 | $-32,612 | $-51,976 | $-56,849 |
| EPS Basic Total Ops | -5.67 | -7.50 | -6.00 | -9.50 | -10.50 |
| EPS Basic Continuous Ops | -5.67 | -7.28 | -5.98 | -9.56 | -10.47 |
| EPS Diluted Total Ops | -5.67 | -7.50 | -6.00 | -9.50 | -10.50 |
| EPS Diluted Continuous Ops | -5.67 | -7.28 | -5.98 | -9.56 | -10.47 |
| EBITDA(a) | $-28,259 | $-33,579 | $-23,954 | $-44,347 | $-49,594 |